Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
Cathie Wood Redirects Elon Musk's DOGE Focus Toward Nuclear Energy Amid Regulatory Challenges: Here's How Oklo, Cameco, Centrus Energy And Other Stocks Performed
Toyota (TM.US), the "auto industry leader", is slow in transitioning to electrification, with a 20% decline in Q2 operating profit.
The global top-selling auto manufacturer saw a 20% year-on-year decline in operating profit. The company maintains the full-year operating profit forecast at 4.3 trillion yen, while raising the full-year dividend forecast from 75 yen a year ago to 90 yen.
Tiziana Life Sciences CEO Discusses Foralumab Potential to Enhance Ozempic - ICYMI | NASDAQ:TLSA
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
Tiziana Life Sciences Secures Funding to Advance Development of MS and Alzheimer's Therapy | NASDAQ:TLSA
Express News | Tiziana Life Sciences Announces Registered Direct Offering of up to Approximately $10 Million
Press Release: Tiziana Life Sciences Announces Registered Direct Offering of up to Approximately $10 Million
Tiziana Life Sciences Reports Promising Preclinical Results for Novel Combination Therapy Targeting Obesity | NASDAQ:TLSA
Express News | Tiziana Life Sciences Ltd - Combination Significantly Reduces Inflammation Markers in Obesity-Related Disorders
Tiziana Life Sciences Announces Positive Results From Ozempic and Nasal Anti-CD3 Combination Study
Express News | Tiziana Life Sciences Announces Positive Results From Ozempic and Nasal Anti-Cd3 Combination Study
Express News | Tiziana Life Sciences - Entered Into Sale Agreement Relating to Issuance and Sale of Common Shares Offered by Prospectus Supplement
Tiziana Life Sciences | 6-K: Report of foreign private issuer (related to financial reporting)
12 Health Care Stocks Moving In Friday's After-Market Session
Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building
Express News | Tiziana Life Sciences Ltd - to Initiate First-in-Human Clinical Trials for Alzheimer's
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer's Disease
Express News | Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-Cd3 in Alzheimer’s Disease
Tesla's Upcoming Robotaxi Event Has Analysts and Investors Guessing